The sale is part of a pre-arranged 10b5-1 plan and follows a recent large disposition, suggesting planned liquidity events rather than reactive selling. Monitor for additional Form 144 or Form 4 filings to assess ongoing insider sentiment. Given the officer status, repeated sales may signal reduced confidence if not fully explained by pre-existing plans.
Price Chart
Executive Summary
Kerry Wentworth, an officer of Nuvation Bio Inc., filed a Form 144 to sell up to 36,750 shares of common stock, valued at approximately $176,768, following the exercise of stock options. The filing also discloses a prior 10b5-1 plan and a previous sale of 200,000 shares for $903,550 on April 6, 2026.
Key Facts
- Kerry Wentworth, an officer of Nuvation Bio Inc., is the reporting owner.
- Filed to sell up to 36,750 shares under Rule 144, with an aggregate value of $176,767.50.
- Shares to be sold were acquired through exercise of stock options on April 17, 2026.
- Sale to be conducted through Morgan Stanley Smith Barney LLC.
- Wentworth previously sold 200,000 shares for $903,550 on April 6, 2026, under a 10b5-1 plan.
Financial Impact
Approximately $176,768 in potential share sales, plus a prior sale of $903,550, totaling about $1.08 million in insider dispositions recently.
Risk Factors
- Perception of insider selling could weigh on investor sentiment, especially following a prior $900K+ sale.
- Potential for increased near-term selling pressure if the 36,750 shares are sold in a short window.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-003615 |
| Document: 0001950047-26-003615-index.html | 0001950047-26-003615 |
| Document: 0001950047-26-003615.txt | 0001950047-26-003615 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 4d ago | Press Release | $4.70 | awaiting T+60 | — | $4.57 (−2.87%) |
Aug 6, 2026 11w ago | 8-K | $6.11 | awaiting T+60 | — | $4.57 (−25.29%) |
Jun 26, 2026 17w ago | 424B5 | $5.61 $6.10 | ▼ −8.73% | ▼ −4.35% | $4.57 (+18.63%) |
Jun 23, 2026 17w ago | 144 | $6.46 $6.07 | ▲ +6.04% | ▲ +8.88% | $4.57 (+29.33%) |
Jun 23, 2026 17w ago | 144 | $6.46 $6.07 | ▼ −6.04% | ▼ −8.88% | $4.57 (−29.33%) |
May 4, 2026 24w ago | 8-K | $4.83 $6.70 | ▲ +38.72% | ▲ +35.98% | $4.57 (−5.49%) |
Apr 21, 2026 26w ago | DEFA14A | $5.11 $5.64 | ▲ +10.37% | ▲ +3.47% | $4.57 (−10.67%) |
Apr 17, 2026 27w ago | 144 | $5.12 $5.90 | ▲ +15.23% | ▲ +8.46% | $4.57 (−10.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers